OtherChemotherapy, Antibiotics, and Gene Therapy
A novel oral indoline-sulfonamide agent, J30, exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule
Jing-Ping Liou, Kuo-Shun Hsu, Ching-Chuan Kuo, Chi-Yen Chang and Jang-Yang Chang
Journal of Pharmacology and Experimental Therapeutics July 27, 2007, DOI: https://doi.org/10.1124/jpet.107.126680
Jing-Ping Liou
Kuo-Shun Hsu
Ching-Chuan Kuo
Chi-Yen Chang
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherChemotherapy, Antibiotics, and Gene Therapy
A novel oral indoline-sulfonamide agent, J30, exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule
Jing-Ping Liou, Kuo-Shun Hsu, Ching-Chuan Kuo, Chi-Yen Chang and Jang-Yang Chang
Journal of Pharmacology and Experimental Therapeutics July 27, 2007, DOI: https://doi.org/10.1124/jpet.107.126680
OtherChemotherapy, Antibiotics, and Gene Therapy
A novel oral indoline-sulfonamide agent, J30, exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule
Jing-Ping Liou, Kuo-Shun Hsu, Ching-Chuan Kuo, Chi-Yen Chang and Jang-Yang Chang
Journal of Pharmacology and Experimental Therapeutics July 27, 2007, DOI: https://doi.org/10.1124/jpet.107.126680
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement